Cipla's bitter pill for MNCs

Several eyebrows have been raised over the Cipla offer to supply anti- aids drugs at one-third the current price to developing countries like South Africa. On March 7, 2001 Cipla Ltd of Mumbai, formally requested the South African department of trade and industry to issue compulsory licenses to patents on hiv drugs such as nevirapine, lamivudine, zidovudine, stavudine, didanosine, efavirenz, indinavir and abacavir.

 
Published: Tuesday 31 July 2001
Subscribe to Weekly Newsletter :

Comments are moderated and will be published only after the site moderator’s approval. Please use a genuine email ID and provide your name. Selected comments may also be used in the ‘Letters’ section of the Down To Earth print edition.